Company Overview of ETEX Corporation
ETEX Corporation develops, manufactures, and commercializes nanocrystalline calcium phosphate-based biomaterials for the repair and regeneration of bone damaged by trauma or disease. It offers porous, injectable, and moldable bone substitute materials; and osteoinductive bone graft substitutes. ETEX Corporation has a strategic partnership with Pfizer. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.ETEX Corporation operates as a subsidiary of Zimmer Biomet Holdings, Inc.
675 Massachusetts Avenue
Cambridge, MA 02139
Founded in 1989
Key Executives for ETEX Corporation
Similar Private Companies By Industry
|Vybion, Inc.||United States|
|AptamiR Therapeutics, Inc.||United States|
|Milo Genetics, LP||United States|
|One Cell Systems, Inc.||United States|
|C2 Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ETEX Corporation, please visit www.etexcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.